Polyphenols as Lung Cancer Chemopreventive Agents by Targeting microRNAs

Lung cancer is the second leading cause of cancer-related death worldwide. In recent decades, investigators have found that microRNAs, a group of non-coding RNAs, are abnormally expressed in lung cancer, and play important roles in the initiation and progression of lung cancer. These microRNAs have been used as biomarkers and potential therapeutic targets of lung cancer. Polyphenols are natural and bioactive chemicals that are synthesized by plants, and have promising anticancer effects against several kinds of cancer, including lung cancer. Recent studies identified that polyphenols exert their anticancer effects by regulating the expression levels of microRNAs in lung cancer. Targeting microRNAs using polyphenols may provide a novel strategy for the prevention and treatment of lung cancer. In this review, we reviewed the effects of polyphenols on oncogenic and tumor-suppressive microRNAs in lung cancer. We also reviewed and discussed the potential clinical application of polyphenol-regulated microRNAs in lung cancer treatment.

Automated summary

Lung cancer is the second leading cause of cancer-related death globally. Abnormal expression of microRNAs has been found in lung cancer and they play important roles in its initiation and progression. Polyphenols, natural bioactive chemicals synthesized by plants, have shown promising anticancer effects against lung cancer and other types of cancer. Recent studies have revealed that polyphenols exert their anticancer effects by regulating the expression levels of microRNAs in lung cancer. Therefore, targeting microRNAs using polyphenols may provide a novel strategy for the prevention and treatment of lung cancer.